Control subject

Of all the above parameters, system voltage is already predefined and considering that it cannot be changed, the only parameters that can be altered to optimize P are Z and B. Both parameters can be altered to any desired limit with the application of reactive power controls, subject to... 

Odour Legislation and controls Subjective, empirical ASTM methods... 

Cowley DS, Roy-Byrne PP, Radant A, et al Eye movement effects of diazepam in sons of alcoholic fathers and male control subjects. Alcohol Clin Exp Res 18 324—332, 1994... 

Before 1980, the mortality rate among younger addicts was up to 20 times higher than that among control subjects it was 2—3 times higher for older ad-... 

Increase In Insulin Dosage Needed to Control Subject... 

Lisboa et al. analyzed the safety and efficacy of lAT on the basis of current published data. They found a total of 27 studies (10 patients minimum) with a total of 852 patients who received lAT and 100 control subjects. There were more favorable outcomes in the lAT than in the control group (41.5% vs. 23%), with a lower mortality rate for lAT (27.2% vs. 40%). The lAT group had an OR of 2.4 for favorable outcomes, despite a higher frequency of symptomatic ICH (9.5% vs. 3%). In addition, they found a trend toward better outcomes with combined IV rt-PA and lAT than with lAT alone. They also remarked that lAT-treated supratentorial strokes are more likely to have favorable outcomes than infratentorial ones (42.2% vs. 25.6%). 

A reversed bridging approach has been proposed by Keris et al. In this study, 12 patients (three ICA occlusions and nine MCA occlusions) out of the 45 enrolled (all with an NIHSS score >20) were randomized to receive an initial lA infusion of 25 mg of rt-PA over 5-10 minutes, followed by IV infusion of another 25 mg over 60 minutes, within 6 hours of stroke onset (total combined dose 50 mg with a maximum dose of 0.7 mg/kg). The remaining 33 patients were assigned to a control group and did not undergo any thrombolysis. TIMI 2 and 3 recanalization occurred in 1 of 12 and 5 of 12 of the patients, respectively. There were no symptomatic ICHs. At 12 months, 83% of the patients in the thrombolysis group were functionally independent, whereas only 33% of the control subjects had a good outcome. 

A PET scan with [ F] fluorodopa in a control subject shows that the striatum is heavily labelled whilst in a Parkinson patient with established symptoms there is little labelling. This patient s twin, whilst free of symptoms, also showed some loss of labelling and subsequently developed the disorder. Reproduced by kind permission of D Brooks, MRC Cyclotron Unit, Hammersmith Hospital, UK. 

The objective of these studies is to find a neurochemical marker for depression. For obvious reasons, the majority has looked for changes that might affect monoamine function and so the following sections concentrate on these neurotransmitters. (Evidence suggesting that a dysfunction of the gluocorticoid hormonal system could be involved is discussed later.) Most techniques compare depressed and non-depressed (control) subjects and measure ... 

Collier et al. (1990) extended their studies relating to oxidative stress and diabetes by demonstrating that the levels of several free-radical scavengers (red cell superoxide dismutase, plasma thiols) were significantly reduced in 22 type 2 diabetic patients (mean age 53 years) in comparison with 15 control subjects (mean age 51 years). No significant diflFerences in red cell lysate thiols or... 

ANSWER We are in the midst of analyzing the data. You will remember that the mean 5-HIAA level in control subjects is approximately 19 to 20. 

Zeibecoglou K, Ying S, Yamada T, et al. Increased mature and immature CCR3 messenger RNA+ eosinophils in bone marrow from patients with atopic asthma compared with atopic and nonatopic control subjects. J Allergy Clin Immunol 1999 103(1 Pt 1) 99-106. 

Arora, R. C. Meltzer, H. Y. (1989). Serotonergic measures in the brains of suicide victims 5-HT(2) binding sites in the frontal cortex of suicide victims and control subjects. Am. J. Psychiatry, 146, 730-6. 

Necheles et al. (N4) first reported a genetically determined homozygous GSH-Px deficiency associated with neonatal jaundice and mild hemolysis. Spontaneous recovery from hemolysis was noted 3 months after birth. Thereafter, several cases with GSH-Px deficiency were reported. Newborn infants exhibit significantly lower red blood cell GSH-Px activity and serum selenium concentrations than adult control subjects, and a significantly positive correlation between selenium concentration and GSH-Px activity has been observed. Furthermore, the addition of selenium stimulates, both in vivo and in vitro, the GSH-Px activity. The neonatal red blood cell GSH-Px deficiency may be partially due to insufficient availability of selenium during pregnancy (P9). Therefore, the diagnosis of GSH-Px deficiency in newborn infants must be made carefully. 

The comparison of the effectiveness of different tumor markers (old versus new) for a given malignancy should be carried out using split samples from both patients and healthy control subjects (Table 4). Several different decision levels could be used to establish an interpretive scale instead of using a single point. How to establish the decision levels is described in the following ... 

A mean Stanford-Binet IQ decrement of 5 points, fine motor dysfunction, and altered behavioral profiles were found in 70 preschool children exhibiting pica for paint and plaster and elevated PbB levels (>40 pg/dL, mean of 58 pg/dL), when compared with results for matched control subjects not engaged in... 

It is noteworthy that some epidemiological studies have found that lycopene, but not lutein nor zeaxanthin, is substantially decreased in serum of AMD patients compared with age-matched control subjects (Cardinault et al., 2005). 

Sanders, TA, Haines, AP, Wormald, R, Wright, LA, and Obeid, O, 1993. Essential fatty acids, plasma cholesterol, and fat-soluble vitamins in subjects with age-related maculopathy and matched control subjects. Am J Clin Nutr 57, 428-433. 

Figure 5.1 Visualization of the distribution of the DA transporter, D3 receptor, and K2-opioid receptor in the human brain of a drug-free control subject and a representative cocaine overdose victim. (A, B) The DA transporter was measured using [3H]WIN 35,428 (2 nM) as described previously. (C, D) The D3 receptor was measured using [3H]-(+)-7-OH-DPAT (1 nM) in the presence of GTP (300 m/W) to enhance the selective labeling of the D3 receptor subtype over the D2 receptor subtype as described previously. (E, F) The K2-opioid receptor subtype was measured using [125l]IOXY on tissue sections pretreated with BIT and FIT to occlude binding to the p- and 8-opioid receptors, respectively.

---